We are enclosing herewith a press release issued by the Company titled:
Solara completes yet another USFDA Inspection with zero 483s
Solara Active Pharma Sciences: Announcement under Regulation 30 (LODR)-Press Release / Media Release
28-Jan-2019
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month